"Hunterdon Regional Cancer Center is committed to providing high-quality care to every patient who enters our doors for consultation, education, treatment or follow-up care. Like all excellent cancer centers, Hunterdon Regional Cancer Center is accredited by the American College of Surgeons Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC)."

During the past decade, Hunterdon Regional Cancer Center at Hunterdon Medical Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 14 clinical trials were completed, i.e. on average, 1400% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hunterdon Regional Cancer Center at Hunterdon Medical Center" #1 sponsor was "Eastern Cooperative Oncology Group" with 18 trials, followed by "Fox Chase Cancer Center" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "NSABP Foundation Inc" with 5 trials sponsored and "SWOG Cancer Research Network" with 5 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hunterdon Regional Cancer Center at Hunterdon Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 45 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Hunterdon Regional Cancer Center at Hunterdon Medical Center" are "Breast Cancer" (11 trials), "Lung Cancer" (10 trials), "Colorectal Cancer" (6 trials), "Kidney Cancer" (3 trials) and "Lymphoma" (3 trials). Many other conditions were trialed in "Hunterdon Regional Cancer Center at Hunterdon Medical Center" in a lesser frequency.

Most popular intervention types in "Hunterdon Regional Cancer Center at Hunterdon Medical Center" are "Drug" (41 trials), "Biological" (15 trials), "Other" (7 trials), "Radiation" (6 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "paclitaxel" (9 trials), "cisplatin" (5 trials), "radiation therapy" (5 trials), "carboplatin" (4 trials) and "cyclophosphamide" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hunterdon Regional Cancer Center at Hunterdon Medical Center" are 39 trials for "All" genders, 11 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hunterdon Regional Cancer Center at Hunterdon Medical Center". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Hunterdon Regional Cancer Center at Hunterdon Medical Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hunterdon Regional Cancer Center at Hunterdon Medical Center, 0 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".